GVB Biopharma
- Company typePrivate
- Founded2016
- HeadquartersLas Vegas, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
GVB Biopharma firmographics
Firmographics- Name
- GVB Biopharma
- Legal name
- GVB Biopharma
- Website
- https://gvbbiopharma.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
GVB Biopharma industry classification
Industry- Product category
- Hemp Cannabinoid Ingredients
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Hemp & CBD Product Wholesale Distribution (CRAOAIAG)
Keywords
Where GVB Biopharma is headquartered
LocationHeadquarters
- HQ city
- Las Vegas
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
GVB Biopharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Bulk Ingredients Sales: Wholesale sale of raw hemp-derived cannabinoid materials including isolates (CBD, CBG, CBN, CBDa, CBC, CBDv, CBT, CBE, CBL, CBGa), distillates (Full Spectrum, Broad Spectrum, Crystal Resistant, Ultra-Broad Spectrum, Organic, CBN-Free), crude oil, biomass, and water-soluble formulations. Revenue generated through per-kilogram/unit pricing with volume discounts for larger orders.
- White Label Product Manufacturing: Custom formulation and manufacturing of finished cannabinoid products for brands including tinctures, capsules, gummies, mints, tablets, topicals (balms, salves, creams, lotions), bath bombs, vapes, and pet products. Revenue generated through per-unit manufacturing fees with customization charges.
- International Distribution: International sales operations including GVB UK and GVB EU divisions, shipping bulk cannabinoid extracts around the world with expanding international presence in wholesale cannabinoid community.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Bulk ingredient orders by weight (10g to 1kg+) |
| Unit Pricing | Pay-as-you-go | White label custom formulations |
| Unit Pricing | Pay-as-you-go | Pre-formulated white label products |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
GVB Biopharma product offering
Product offeringCore offering
GVB Biopharma is a vertically integrated hemp processor that manufactures and wholesale-distributes bulk cannabinoid raw ingredients (isolates and distillates spanning CBD, CBG, CBN, and minor cannabinoids) and produces custom white label finished products (tinctures, capsules, gummies, topicals, vapes, pet products) for brands, retailers, and manufacturers. Production relies on proprietary cryogenic extraction, proprietary enzymatic CBN conversion, and Crystal Resistant Distillate processes, with full third-party lab verification and COAs on every batch.
Product overview
GVB Biopharma is a vertically integrated hemp cannabinoid company offering two main product categories: Bulk Ingredients and White Label finished products. Bulk Ingredients include Isolate products (CBD, CBG, CBN, CBDa, CBC, CBDv, CBT, CBL, CBGa, CBE) and Distillate products (Full Spectrum Compliant, Broad Spectrum, Crystal Resistant, CBN, CBG, Ultra-Broad Spectrum, Organic, CBN-Free, H4CBD). White Label offerings span multiple delivery formats: Ingestibles (Tinctures, Capsules, Mints/Tablets, Gummies), Topicals (Balms/Salves, Creams, Lotions, Bath Bombs, Face Serums), Vapes, and Pet Products. The company operates with proprietary cryogenic extraction and proprietary enzymatic conversion processes, providing seed-to-shelf quality control from select hemp genetics.
Differentiator
Problem solved
Functional benefit
Brands
- GVB UK: United Kingdom division of GVB Biopharma serving the UK market.
- GVB EU
Products and services
- Bulk Ingredients - Isolate Wholesale hemp-derived cannabinoid isolates including CBD Isolate (≥98% CBD), CBG Isolate (≥98% CBG), CBN Isolate (≥97% CBN), CBDa Isolate (90-95%), CBC Isolate (95-99%), CBDv Isolate (95-99%), CBT Isolate (≥94%), CBL Isolate, CBGa Isolate, and CBE Isolate. Sold as flavorless crystalline powders purified to remove oils, waxes, chlorophyll, and terpenes for brands, formulators, and manufacturers.
- Bulk Ingredients - Distillate Wholesale hemp-derived cannabinoid distillates including Full Spectrum Compliant CBD Distillate (85-90% CBD, 0.15-0.25% THC), Broad Spectrum THC-free Distillate (85-92% CBD), Crystal Resistant Distillate (30-50% CBD with 12-25% minor cannabinoids), CBN Distillate (70-85%), CBG Distillate (70-85%), Ultra-Broad Spectrum CBD Distillate, CCOF-certified Organic CBD Distillate, Broad Spectrum CBN-Free CBD Distillate, and H4CBD Distillate (95-99%).
- White Label - Ingestibles White label finished ingestible products including Tinctures (customizable cannabinoid profiles and botanicals), Capsules (soft gels with customizable strength and ingredients), Mints & Tablets, and Gummies (gluten-free, vegan, natural flavors/colors) for brands and retailers building their own hemp/cannabinoid product lines.
- White Label - Topicals White label topical products including Balms & Salves (hemp-infused, absorbable targeted relief), Creams (water-based with micellized CBD), Lotions & Body Lotions, Bath Bombs, and Face Serums for brands and retailers selling topical cannabinoid SKUs.
- White Label - Vapes White label vaporizer products formulated with various cannabinoid extracts for inhalation delivery, sold to brands and retailers building vape product lines.
- White Label - Pet Products White label CBD products formulated for pets including Pet Products, Pet Tinctures, and Pet Balms (moisturizing care for dry, cracked paws and noses) sold to brands serving the pet wellness category.
Companies that use GVB Biopharma
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
GVB Biopharma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
GVB Biopharma partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights5 records
GVB Biopharma competitors and assessment
Company assessmentDirect peers
- Medterra: CBD ingredients and white label/finished products company serving brands and retailers, with vertically integrated extraction and GMP-grade manufacturing comparable to GVB.
- Bluebird Botanicals: Hemp extraction company producing CBD isolates, distillates, and finished cannabinoid products for B2B and B2C, overlapping with GVB across ingredients and finished formulations.
- Global Cannabinoids: Direct competitor in bulk hemp-derived cannabinoid ingredients (isolates and distillates) plus white label finished products, serving the same B2B brand and manufacturer customer base as GVB.
- Extract Labs: Vertically integrated hemp extraction and white label manufacturer producing isolates, distillates, and finished CBD products for B2B and DTC channels — closely overlapping GVB's product mix.
- Hemp Depot: Vertically integrated hemp producer and bulk CBD/wholesale ingredient supplier competing directly with GVB in raw material and finished product channels.
- Kazmira: Vertically integrated hemp extraction and white label manufacturer offering bulk CBD ingredients and finished product manufacturing for B2B customers — highly comparable to GVB's model.
- Mile High Labs: Large-scale hemp-derived CBD isolate and distillate producer supplying bulk ingredients and white label services to brands globally, directly comparable to GVB's ingredient business.
- Pure Hemp Botanicals: CBD extraction and white label manufacturer producing bulk cannabinoid ingredients and finished products for wholesale customers — directly comparable to GVB's offering.
Broad incumbents
- cbdMD: Public hemp-derived cannabinoid brand with vertically integrated extraction and broad SKU portfolio spanning isolates, topicals, ingestibles, and pet products — broader portfolio but overlapping with GVB's categories.
- Charlotte's Web: One of the largest and most established vertically integrated hemp-derived CBD producers with its own branded CPG portfolio; overlaps with GVB in extraction and white label but operates at a much larger branded scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
GVB Biopharma social profiles
Digital presenceGVB Biopharma compliance and trust
Trust signalCompliance6 records
GVB Biopharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
GVB Biopharma leadership team
Management profileNumber of profiles
Profiles2 records
GVB Biopharma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GVB Biopharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GVB Biopharma
What does GVB Biopharma do?
GVB Biopharma is a vertically integrated hemp processor that manufactures and wholesale-distributes bulk cannabinoid raw ingredients (isolates and distillates spanning CBD, CBG, CBN, and minor cannabinoids) and produces custom white label finished products (tinctures, capsules, gummies, topicals, vapes, pet products) for brands, retailers, and manufacturers. Production relies on proprietary cryogenic extraction, proprietary enzymatic CBN conversion, and Crystal Resistant Distillate processes, with full third-party lab verification and COAs on every batch.
Is GVB Biopharma a public or private company?
GVB Biopharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was GVB Biopharma founded?
GVB Biopharma was founded in 2016. It employs 101 to 250 people.
Where is GVB Biopharma based?
GVB Biopharma is headquartered in Las Vegas, United States, in the North America region.
How does GVB Biopharma make money?
Three revenue lines are on record. Bulk Ingredients Sales are the primary driver. The others are white Label Product Manufacturing and international Distribution.
Who are GVB Biopharma's main competitors?
Direct peers on record are Medterra, Bluebird Botanicals, Global Cannabinoids, Extract Labs, Hemp Depot, Kazmira, Mile High Labs and Pure Hemp Botanicals. Broad incumbents are cbdMD and Charlotte's Web.
Does GVB Biopharma have an API?
No public API is recorded for GVB Biopharma.
What industry is GVB Biopharma in?
GVB Biopharma's product category is Hemp Cannabinoid Ingredients. Its primary akta.pro industry code is CRAOAIAG, Hemp & CBD Product Wholesale Distribution. Its NAICS code is 325414 and its SIC code is 2833.